MK-677 (also known as ibutamoren or MK-0677) is an orally active ghrelin receptor (GHSR-1a) agonist that increases pul ...

Verzenio plus endocrine therapy reduced death risk by 15.8% in high-risk early breast cancer patients compared to endocrine ...

The decision by the Canadian regulator is supported by the findings from the Phase III DESTINY-Breast06 study.

The European Society for Endocrinology (ESE) and the European Society for Paediatric Endocrinology (ESPE) have released today ...

Mayo Clinic researchers collaborated on a new study led by Eli Lilly showing that the drug abemaciclib improves survival for ...

Abemaciclib plus endocrine therapy significantly improved overall survival, IDFS, and DRFS in HR-positive, HER2-negative, node-positive early breast cancer. Adjuvant abemaciclib (Verzenio; Eli Lilly) ...

Research has suggested the potential of GLP-1 medications for treating substance use disorders, including alcohol, opioids, ...

Endocrine therapy remains a backbone of adjuvant therapy for women with hormone receptor–positive early-stage breast cancer. Numerous studies have demonstrated the benefit of ovarian function ...

Experts discuss the integration of GLP-1 receptor agonists in treating neuroendocrine tumors, highlighting safety concerns and the need for further research.

BERLIN -- For the first time in a phase III trial, adjuvant treatment with a CDK4/6 inhibitor significantly improved overall ...

In vertebrates, calcium is stored in bones, and its release is tightly regulated. Now, using fruit flies as a model organism, researchers at University of Tsukuba have shown that even animals without ...